TrialThe Pediatric infectious disease journal2019

Safety and Immunogenicity of a Full-dose, Split-virion, Inactivated, Quadrivalent Influenza Vaccine in Healthy Children 6-35 Months of Age: A Randomized Controlled Clinical Trial.

Corwin A Robertson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.